Evotec SE (EVO) Capital Expenditures (2009 - 2026)
Evotec SE (EVO) posted Capital Expenditures of -$4873.8 for Q1 2026, down 100.01% sequentially from $84.5 million in Q4 2025, and up 74.54% YoY from -$2792.4 in Q1 2025.
Evotec SE (EVO) Capital Expenditures (2009 - 2026) Analysis & Trends
Evotec SE has reported Capital Expenditures for 9 years, with the latest figure at -$4873.8 in Q1 2026.
- Quarterly Capital Expenditures rose 74.54% year-over-year to -$4873.8 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $84.5 million (down 32.73% YoY) and the FY2025 annual result came in at $84.4 million, down 32.73% from the prior year.
- Capital Expenditures retreated to -$4873.8 in Q1 2026 per EVO's latest filing, from $84.5 million in the prior quarter.
- Over five years, Capital Expenditures peaked at $229.7 million in Q4 2023 and troughed at -$160225.4 in Q2 2023.
- A 5-year average of $36.7 million and a median of -$22004.2 in 2025 frame the typical range for Capital Expenditures.
- The widest YoY moves for Capital Expenditures: up 638.8% in 2022, down 109924.74% in 2022.
- Over 5 years, Capital Expenditures stood at $184.9 million in 2022, then advanced by 24.24% to $229.7 million in 2023, then tumbled by 45.3% to $125.6 million in 2024, then sank by 32.73% to $84.5 million in 2025, then sank by 100.01% to -$4873.8 in 2026.
- According to Business Quant data, Capital Expenditures over the past three periods registered -$4873.8, $84.5 million, and -$23625.4 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.40 Bn | 43.44 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.68 Bn | 40.02 Bn | 2.15 Bn | 104.00 Mn |
| 3 | Zoetis | 32.31 Bn | 30.63 Bn | 1.05 Bn | 117.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | -337.60 Mn |
| 5 | United Therapeutics | 21.98 Bn | 19.32 Bn | 683.80 Mn | 108.00 Mn |
| 6 | Viatris | 18.87 Bn | 17.98 Bn | 1.46 Bn | 52.80 Mn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 7.80 Mn |
| 8 | Elanco Animal Health | 11.97 Bn | 11.44 Bn | 798.00 Mn | 33.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Evotec SE | 692.56 Mn | 692.08 Mn | - | -4,873.81 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4,873.81 |
| Mar 31, 2026 | -4,873.81 |
| Dec 31, 2025 | 84.51 Mn |
| Dec 31, 2025 | 84.51 Mn |
| Sep 30, 2025 | -23,625.43 |
| Sep 30, 2025 | -23,625.43 |
| Jun 30, 2025 | -22,004.16 |
| Jun 30, 2025 | -22,004.16 |
| Mar 31, 2025 | -19,142.19 |
| Mar 31, 2025 | -19,142.19 |
| Dec 31, 2024 | 125.64 Mn |
| Dec 31, 2024 | 125.64 Mn |
| Sep 30, 2024 | -29,405.93 |
| Sep 30, 2024 | -29,405.93 |
| Jun 30, 2024 | -37,963.52 |
| Jun 30, 2024 | -37,963.52 |
| Mar 31, 2024 | -43,711.94 |
| Mar 31, 2024 | -43,711.94 |
| Dec 31, 2023 | 229.68 Mn |
| Dec 31, 2023 | 229.68 Mn |